Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Cetuximab and Drug Combination for Patients with Metastatic Colorectal Cancer
ItalyStudy on Treating Knee Osteoarthritis with Nasal Cartilage Implantation for Patients with Patellofemoral Osteoarthritis
ItalyStudy on the Safety and Effects of DNL593 for Patients with Frontotemporal Dementia
ItalyStudy on the Effects of Acetylsalicylic Acid and Cytisine for High-Risk Patients in Preventing Lung Cancer and Reducing Inflammation
ItalyStudy of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo
ItalyStudy on Eptinezumab for Migraine: Understanding How It Works and Finding Patient Response Markers for Migraine Sufferers
ItalyStudy on the Safety and Effectiveness of Metal Panel Allergens for Patients with Allergic Contact Dermatitis
ItalyStudy Comparing Ifinatamab Deruxtecan and Docetaxel for Patients with Advanced Prostate Cancer Resistant to Hormone Therapy
ItalyStudy on the Effectiveness and Safety of IMVT-1402 for Adults with Graves' Disease
ItalyStudy on Cemiplimab and Mitotane for Patients with Advanced Adrenocortical Cancer
ItalyStudy of Faricimab Treatment Given Every 24 Weeks in Patients with Age-Related Macular Degeneration
ItalyStudy on Long-Term Safety and Efficacy of VX-670 for Adults with Myotonic Dystrophy Type I
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
